![](/img/cover-not-exists.png)
Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden: Analysis Using 28-Month Overall Survival from Checkmate 067
Baker, T, Paly, VF, Sabater, J, Holmberg, C, Hultberg, M, Lundström, J, Minacori, R, Chirita, OVolume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.261
Date:
October, 2017
File:
PDF, 62 KB
english, 2017